FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Sodium Acetate Injection, USP
Status: Currently in Shortage
»Date first posted: 02/03/2016
»Therapeutic Categories: Total Parenteral Nutrition

Expand all

Fresenius Kabi USA, LLC (Revised 09/11/2017)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
32.8% 400 mEq 100mL PBP (NDC 63323-0032-61) Backordered. Next release anticipated October 2017. Check Wholesalers for Inventory Demand increase for the drug

Hospira, Inc. (Revised 08/28/2017)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2 mEq/mL; 100 mEq/50 mL Pharmacy Bulk Package Glass Fliptop Vial (NDC 0409-3299-05) Next delivery: Late August 2017; Estimated recovery: November 2017 Shortage per manufacturer: Manufacturing Delay

Dear Customer Letter

Other
2 mEq/mL; 200 mEq/100 mL Pharmacy Bulk Package Glass Fliptop Vial (NDC 0409-3299-06) Next delivery: Late August 2017; Estimated recovery: December 2017 Shortage per manufacturer: Manufacturing Delay

Dear Customer Letter

Other
2 mEq/mL; 40 mEq/20 mL Single Dose Plastic Fliptop Vial (NDC 0409-7299-73) Next delivery: Mid September 2017; Estimated recovery: December 2017 Shortage per manufacturer: Manufacturing Delay

Dear Customer Letter

Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English